ARCA biopharma, Inc.·4

Mar 5, 5:33 PM ET

MITCHELL DANIEL J 4

4 · ARCA biopharma, Inc. · Filed Mar 5, 2018

Insider Transaction Report

Form 4
Period: 2018-03-01
Transactions
  • Award

    Stock Option (right to buy)

    2018-03-01+8,0008,000 total
    Exercise: $0.72Exp: 2028-02-29Common Stock (8,000 underlying)
Holdings
  • Common Stock

    11,000
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the 2013 Amended and Restated Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 1, 2018. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION